IP Library Granted Patent US 8,137,302
Granted Patent B2
US 8,137,302 · App. 11/684,950 · Granted Mar 20, 2012

Methods and systems for occluding collateral flow channels in the lung

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,137,302
App. No.
11/684,950
Granted
Mar 20, 2012
Kind
B2
Abstract

The lateral flow between adjacent lung segments is occluded by blocking collateral flow channels with particles. A gas flow is established from one lung segment through the flow channels in an intermediate fibrous septum, and out through the adjacent lung segment. Particles entrained in the gas flow become lodged in the collateral flow channels to eventually block flow.

Claims (23)

1. A method for occluding collateral flow channels between adjacent lung segments, said method comprising:

providing a distribution of particles having a composition and a range of sizes from 100 μm to 1000 μm selected to lodge in and occlude the collateral flow channels;

establishing a gas flow through the collateral flow channels in a wall between the at least two adjacent lung segments; and

entraining the particles in said gas flow, wherein the particles lodge in the flow channels to occlude collateral flow.

2. A method as in claim 1 , wherein the particles are composed at least partly from a material selected from the group consisting of silicones, polyurethanes, collagen, hydroxy apatites, sol-gels, ceramic sol-gels, bone cements, and hemo glues.

3. A method as in claim 1 , wherein the particles are composed of a hydrogel.

4. A method as in claim 1 , wherein the particles have a surface that has been modified to induce an inflammatory response when implanted.

5. A method as in claim 1 , wherein the collateral channels have walls, and the particles induce adherence of the walls of the collateral channels to close and adhere.

6. A method as in claim 1 , wherein the particles release a drug which promotes tissue ingrowth.

7. A method as in claim 6 , wherein the drug is selected from the group comprising collagen and/or any derivative drug that promotes tissue growth.

8. A method as in claim 1 , wherein establishing comprises:

sealing a distal end of a catheter in an airway feeding a target lung segment, wherein the catheter provides an isolated passage between the target lung segment and an exterior location.

9. A method as in claim 8 , wherein entraining comprises:

combining the particles with a carrier gas being fed into the target lung segment through the isolated passage in the catheter.

10. A method as in claim 9 , wherein the carrier gas comprises excess oxygen to induce or promote absorption atelectasis.

11. A method as in claim 10 , further comprising exhaling through a path which bypasses isolated passage in the catheter.

12. A method as in claim 11 , wherein the bypass path is through a separate passage in the catheter.

13. A method as in claim 11 , wherein the bypass path is through an annular region surrounding the catheter.

14. A method as in claim 8 , wherein entraining comprises:

combining the particles with a carrier gas being fed to a lung segment adjacent to the target lung segment, wherein the carrier gas carries the particles into the collateral flow channels and the gas is exhaled at least partially through the isolated passage.

15. A method as in claim 14 , wherein the carrier gas is introduced through a second passage in the catheter which releases the carrier gas upstream of the sealed distal end of the catheter.

16. A method as in claim 14 , further comprising blocking all gas flow to and from the target and adjacent lung compartment(s) other than through the catheter passage(s).

17. A method as in claim 16 , wherein blocking comprises inflating a cuff on a bronchoscope, wherein the catheter passes through a passage in the bronchoscope.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2007
From: ALJURI, NIKOLAI; VENEGAS, JOSE G.; NAIR, AJIT; PERKINS, RODNEY C.
To: PULMONX
Reel/Frame 019233/0168 →